Australian AI biotech firm Opyl, listed on the ASX, has implemented a strategic move by acquiring approximately 2 BTC, valued at around $214,500, via DigitalX’s Bitcoin ETF. This initiative forms part of Opyl’s newly launched Bitcoin Treasury strategy, designed to stabilize its financial position amid liquidity challenges. The acquisition is supported by a non-dilutive loan facility from SOL Strategies Chairman Tony G, capped at $1.3 million with a 6.5% annual interest rate. This financial maneuver comes after Opyl reported a cash reserve of only $64,000 at the close of Q1, highlighting the company’s urgent need for capital optimization. By integrating cryptocurrency assets into its treasury, Opyl aims to leverage Bitcoin’s potential as a store of value while navigating market uncertainties. This development underscores a growing trend among ASX-listed companies adopting digital assets to enhance balance sheet resilience and diversify financial risk.